logo

For the Inventor, By the Inventor

San Diego, CA, United States of America

Quidel Corporation


USPTO Granted Patents = 88

% Expired Patents = 14.8



Forward Citations = 3,313

Loading Chart...
Loading Chart...

131 inventors (with patents filed for the assignee):

goldMedal Allan D Pronovost (18 out of 28 patents)

silverMedal Hans R Boehringer (12 out of 14 patents)

bronzeMedal Bruce L Jacono (9 out of 9 patents)

4.  Paul Lambotte (8 out of 9 patents)

5.  Jhobe Steadman (7 out of 9 patents)

6.  Jeremy Jerome (7 out of 7 patents)

7.  Mark Daquipa (7 out of 7 patents)

8.  Jason McClure (6 out of 16 patents)

9.  Paul J Lawrence (6 out of 32 patents)

10.  Robert Reed (5 out of 8 patents)

11.  Robert Weiller (5 out of 8 patents)

12.  David Dickson Booker (5 out of 5 patents)

13.  Michael Cerrito (5 out of 6 patents)

14.  Cecille Ramirez (5 out of 6 patents)

15.  Jan W Pawlak (5 out of 5 patents)


Core Competencies:
Immunoassay
Point-of-Care Testing
Fluid Flow
Disease Diagnostics
Analyte Detection
Microfluidic Devices
Blood Separation
Rapid Tests
Diagnostic Assays
Autoantibodies
Lateral Flow Assays
Enzyme Immunoassays

88 patents:

1. 12681016 - COMPOSITIONS AND METHODS FOR DETECTING AUTOANTIBODIES (2026-07-14),
2. 12174185 - Compositions and methods for detecting autoantibodies (2024-12-24),
3. 12055542 - System and methods for remote assessment of a sample assay for disease diagnostics (2024-08-06),
4. 11953428 - Method for reducing analyzer variability using a normalization target (2024-04-09),
5. 11846637 - Immunoassay test device with two fluid flow paths for detection and differentiation of two or more analytes (2023-12-19),
6. 11783563 - Software and algorithms for use in remote assessment of disease diagnostics (2023-10-10),
7. 11674961 - Extraction reagent for use in an assay for detection of group A (2023-06-13),
8. 11650200 - Device for whole blood separation (2023-05-16),
9. 11560584 - Phage-mediated immunoassay and methods for determining susceptibility of bacteria to antibiotic or probiotic agents (2023-01-24),
10. 11548938 - DbpA antibodies and uses thereof (2023-01-10),
11. 11446654 - Substrate with channels for controlled fluid flow (2022-09-20),
12. 11131670 - Immunoassay test device with two fluid flow paths for detection and differentiation of two or more analytes (2021-09-28),
13. 11131666 - System and apparatus for point-of-care diagnostics (2021-09-28),
14. 11061020 - Interactive test device and apparatus with timing mechanism (2021-07-13),
15. 10908145 - Device for whole blood separation (2021-02-02),
Quidel Corporation, based in San Diego, CA, specializes in the development and manufacturing of innovative diagnostic solutions for various diseases. The company focuses on immunoassay technologies and point-of-care testing, enabling rapid and accurate disease detection. Quidel's expertise extends to fluid flow and analyte detection, utilizing advanced microfluidic devices and blood separation techniques to enhance diagnostic capabilities. Their commitment to improving healthcare outcomes positions them as a leader in the field of disease diagnostics.
Profile summary based on public USPTO records.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

88 Patents

#70 in San Diego, CA

#983 in California

#4,232 in US

#8,668 in the World

San Diego, CA (US)
San Diego, CA, United States of America

Quidel Corporation

Forward Citations = 3,313

131 inventors:

goldMedal Allan D Pronovost (18 out of 28 patents)

silverMedal Hans R Boehringer (12 out of 14 patents)

bronzeMedal Bruce L Jacono (9 out of 9 patents)

4.  Paul Lambotte (8 out of 9 patents)

5.  Jhobe Steadman (7 out of 9 patents)

Please report any incorrect information to [email protected]
Loading…